Relapse Multiple Myeloma: Clinical Trials

1 trial for Relapse Multiple Myeloma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Unknown 1

Follow Relapse Multiple Myeloma: new trials by email Literature Review of Relapse Multiple Myeloma trials Research Report on Relapse Multiple Myeloma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) Versus Pomalidomide-Dexamethasone (PD) in Relapse or Refractory Myeloma
PCD, PD - Relapse Multiple Myeloma
Phase 3UnknownNational University Hospital, Singapore1202017-09-132017-11-06

Sponsors

National University Hospital, Singapore (1)

Countries

Hong Kong (1)  ·  Japan (1)  ·  Singapore (1)  ·  South Korea (1)  ·  Taiwan (1)

Top investigators

Wee Joo Chng (1)

Results publications

PMID 41052983